LONDON, March 7, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of ...
On March 2, BGI’s Multiplex Real-time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2, Influenza A Virus and Influenza B Virus obtained market access qualification to enter the Australian Register of ...
In a recent study posted to the medRxiv* server, researchers in Germany and Switzerland evaluated 11 commercial reverse transcription-polymerase chain reaction (RT-PCR) kits (A to L) for Monkeypox ...
Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in some European and Gulf ...
Respiratory syncytial virus (RSV) was detected easiest when using reverse transcription polymerase chain reaction (RT-PCR) tests in a pediatric population. Reverse transcription polymerase chain ...
Virax Biolabs Group Ltd (NASDAQ:VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus (AIV) real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results